Global Infectious Diseases Molecular Diagnostics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI06242401

Publication Date:

June 13, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Infectious Diseases Molecular Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the Infectious Diseases Molecular Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Infectious Diseases Molecular Diagnostics market. Infectious Diseases Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Diseases Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Diseases Molecular Diagnostics market.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The Infectious Diseases Molecular Diagnostics market is driven by the need for rapid and accurate diagnostics for infectious diseases and the increasing global incidence of such diseases. Molecular diagnostics offer advanced methods for detecting infectious pathogens and monitoring their genetic variations. The rise in emerging infectious diseases and the demand for point-of-care testing contribute to market growth as healthcare systems seek reliable tools for early detection and effective disease management. Moreover, advancements in diagnostic technologies, including nucleic acid amplification techniques and multiplex assays, align with improved sensitivity and specificity of infectious disease diagnosis. However, the market also faces challenges, including establishing standardized testing protocols and addressing cost barriers for widespread adoption. Additionally, ensuring accessibility and navigating regulatory approvals for new diagnostics can pose obstacles for manufacturers. To succeed, stakeholders must focus on developing innovative molecular diagnostic solutions, collaborating with public health agencies, and addressing the challenges to meet the increasing demand for rapid and accurate detection of infectious diseases.
Key Features:
The report on Infectious Diseases Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infectious Diseases Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction PCR, Molecular Hybridization), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Diseases Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Diseases Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infectious Diseases Molecular Diagnostics industry. This include advancements in Infectious Diseases Molecular Diagnostics technology, Infectious Diseases Molecular Diagnostics new entrants, Infectious Diseases Molecular Diagnostics new investment, and other innovations that are shaping the future of Infectious Diseases Molecular Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Diseases Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Diseases Molecular Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Diseases Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Diseases Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Diseases Molecular Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Diseases Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Diseases Molecular Diagnostics market.
Market Segmentation:
Infectious Diseases Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Segmentation by application
Hospital
Third-party Testing Agency
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size 2019-2030
2.1.2 Infectious Diseases Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infectious Diseases Molecular Diagnostics Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Biochip
2.2.4 Others
2.3 Infectious Diseases Molecular Diagnostics Market Size by Type
2.3.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Infectious Diseases Molecular Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.4.3 Others
2.5 Infectious Diseases Molecular Diagnostics Market Size by Application
2.5.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2019-2024)
3 Infectious Diseases Molecular Diagnostics Market Size by Player
3.1 Infectious Diseases Molecular Diagnostics Market Size Market Share by Players
3.1.1 Global Infectious Diseases Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Diseases Molecular Diagnostics by Regions
4.1 Infectious Diseases Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Infectious Diseases Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC Infectious Diseases Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe Infectious Diseases Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Diseases Molecular Diagnostics by Country (2019-2024)
7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Infectious Diseases Molecular Diagnostics Market Forecast
10.1 Global Infectious Diseases Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Infectious Diseases Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Infectious Diseases Molecular Diagnostics Forecast
10.1.3 APAC Infectious Diseases Molecular Diagnostics Forecast
10.1.4 Europe Infectious Diseases Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast
10.2 Americas Infectious Diseases Molecular Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Infectious Diseases Molecular Diagnostics Market Forecast
10.2.2 Canada Infectious Diseases Molecular Diagnostics Market Forecast
10.2.3 Mexico Infectious Diseases Molecular Diagnostics Market Forecast
10.2.4 Brazil Infectious Diseases Molecular Diagnostics Market Forecast
10.3 APAC Infectious Diseases Molecular Diagnostics Forecast by Region (2025-2030)
10.3.1 China Infectious Diseases Molecular Diagnostics Market Forecast
10.3.2 Japan Infectious Diseases Molecular Diagnostics Market Forecast
10.3.3 Korea Infectious Diseases Molecular Diagnostics Market Forecast
10.3.4 Southeast Asia Infectious Diseases Molecular Diagnostics Market Forecast
10.3.5 India Infectious Diseases Molecular Diagnostics Market Forecast
10.3.6 Australia Infectious Diseases Molecular Diagnostics Market Forecast
10.4 Europe Infectious Diseases Molecular Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Infectious Diseases Molecular Diagnostics Market Forecast
10.4.2 France Infectious Diseases Molecular Diagnostics Market Forecast
10.4.3 UK Infectious Diseases Molecular Diagnostics Market Forecast
10.4.4 Italy Infectious Diseases Molecular Diagnostics Market Forecast
10.4.5 Russia Infectious Diseases Molecular Diagnostics Market Forecast
10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Infectious Diseases Molecular Diagnostics Market Forecast
10.5.2 South Africa Infectious Diseases Molecular Diagnostics Market Forecast
10.5.3 Israel Infectious Diseases Molecular Diagnostics Market Forecast
10.5.4 Turkey Infectious Diseases Molecular Diagnostics Market Forecast
10.5.5 GCC Countries Infectious Diseases Molecular Diagnostics Market Forecast
10.6 Global Infectious Diseases Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global Infectious Diseases Molecular Diagnostics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Infectious Diseases Molecular Diagnostics Product Offered
11.1.3 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Offered
11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Offered
11.3.3 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Offered
11.4.3 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Offered
11.5.3 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Offered
11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Danaher (Cepheid)
11.7.1 Danaher (Cepheid) Company Information
11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered
11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Danaher (Cepheid) Main Business Overview
11.7.5 Danaher (Cepheid) Latest Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Information
11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered
11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics Main Business Overview
11.8.5 Myriad Genetics Latest Developments
11.9 DAAN Gene
11.9.1 DAAN Gene Company Information
11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered
11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 DAAN Gene Main Business Overview
11.9.5 DAAN Gene Latest Developments
11.10 Agilent
11.10.1 Agilent Company Information
11.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Offered
11.10.3 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Agilent Main Business Overview
11.10.5 Agilent Latest Developments
11.11 Genomic Health
11.11.1 Genomic Health Company Information
11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Offered
11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genomic Health Main Business Overview
11.11.5 Genomic Health Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Infectious Diseases Molecular Diagnostics Product Offered
11.12.3 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Information
11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered
11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Foundation Medicine Main Business Overview
11.13.5 Foundation Medicine Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂